Ivermectin was developed in the 1970s and is a semi-synthetic derivative of the avermectins (macrocyclic lactones) that are obtained from fermentation products of Streptomyces avermectinius. It was initially used in veterinary practice to treat parasitic diseases in small and large vertebrates, and was first reported as a treatment for scabies in humans in 1987.